Psychiatric Digital Biomarkers Market Size, Share, Trends and Forecast by Type, Clinical Practice, End Use, and Region, 2025-2033

Psychiatric Digital Biomarkers Market Size, Share, Trends and Forecast by Type, Clinical Practice, End Use, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A27746

1    Preface
2    Scope and Methodology 

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Global Psychiatric Digital Biomarkers Market – Introduction

4.1    What is a Psychiatric Digital Biomarkers
4.2    Industry Trends
4.3    Competitive Intelligence
5    Global Psychiatric Digital Biomarkers Market Landscape
5.1    Historical and Current Market Trends (​2019-2024​)
5.2    Market Forecast (2025-2033)
6    Global Psychiatric Digital Biomarkers Market - Breakup by Type
6.1    Wearable
6.1.1    Overview
6.1.2    Historical and Current Market Trends (​2019-2024​)
6.1.3    Market Forecast (2025-2033)
6.1.4    Market Breakup by Clinical Practice
6.1.5    Market Breakup by End Use
6.2    Mobile based Applications
6.2.1    Overview
6.2.2    Historical and Current Market Trends (​2019-2024​)
6.2.3    Market Forecast (2025-2033)
6.2.4    Market Breakup by Clinical Practice
6.2.5    Market Breakup by End Use
6.3    Sensors
6.3.1    Overview
6.3.2    Historical and Current Market Trends (​2019-2024​)
6.3.3    Market Forecast (2025-2033)
6.3.4    Market Breakup by Clinical Practice
6.3.5    Market Breakup by End Use
6.4    Others
6.4.1    Overview
6.4.2    Historical and Current Market Trends (​2019-2024​)
6.4.3    Market Forecast (2025-2033)
6.5    Attractive Investment Proposition by Type
7    Global Psychiatric Digital Biomarkers Market - Breakup by Clinical Practice
7.1    Diagnostic Psychiatric Digital Biomarkers
7.1.1    Overview
7.1.2    Historical and Current Market Trends (​2019-2024​)
7.1.3    Market Forecast (2025-2033)
7.1.4    Market Breakup by Type
7.1.5    Market Breakup by End Use
7.2    Monitoring Psychiatric Digital Biomarkers
7.2.1    Overview
7.2.2    Historical and Current Market Trends (​2019-2024​)
7.2.3    Market Forecast (2025-2033)
7.2.4    Market Breakup by Type
7.2.5    Market Breakup by End Use
7.3    Predictive and Prognostic Psychiatric Digital Biomarkers
7.3.1    Overview
7.3.2    Historical and Current Market Trends (​2019-2024​)
7.3.3    Market Forecast (2025-2033)
7.3.4    Market Breakup by Type
7.3.5    Market Breakup by End Use
7.4    Others
7.4.1    Overview
7.4.2    Historical and Current Market Trends (​2019-2024​)
7.4.3    Market Forecast (2025-2033)
7.5    Attractive Investment Proposition by Clinical Practice
8    Global Psychiatric Digital Biomarkers Market - Breakup by End Use
8.1    Healthcare companies
8.1.1    Overview
8.1.2    Historical and Current Market Trends (​2019-2024​)
8.1.3    Market Forecast (2025-2033)
8.1.4    Market Breakup by Type
8.1.5    Market Breakup by Clinical Practice
8.2    Healthcare Providers
8.2.1    Overview
8.2.2    Historical and Current Market Trends (​2019-2024​)
8.2.3    Market Forecast (2025-2033)
8.2.4    Market Breakup by Type
8.2.5    Market Breakup by Clinical Practice
8.3    Payers
8.3.1    Overview
8.3.2    Historical and Current Market Trends (​2019-2024​)
8.3.3    Market Forecast (2025-2033)
8.3.4    Market Breakup by Type
8.3.5    Market Breakup by Clinical Practice
8.4    Others
8.4.1    Overview
8.4.2    Historical and Current Market Trends (​2019-2024​)
8.4.3    Market Forecast (2025-2033)
8.5    Attractive Investment Proposition by End Use
9    Global Psychiatric Digital Biomarkers Market – Breakup by Region
9.1    North America
9.1.1    United States
9.1.1.1    Market Drivers
9.1.1.2    Historical and Current Market Trends (​2019-2024​)
9.1.1.3    Market Breakup by Type
9.1.1.4    Market Breakup by Clinical Practice
9.1.1.5    Market Breakup by End Use
9.1.1.6    Key Players
9.1.1.7    Market Forecast (2025-2033)
9.1.2    Canada
9.1.2.1    Market Drivers
9.1.2.2    Historical and Current Market Trends (​2019-2024​)
9.1.2.3    Market Breakup by Type
9.1.2.4    Market Breakup by Clinical Practice
9.1.2.5    Market Breakup by End Use
9.1.2.6    Key Players
9.1.2.7    Market Forecast (2025-2033)
9.2    Asia Pacific
9.2.1    China
9.2.1.1    Market Drivers
9.2.1.2    Historical and Current Market Trends (​2019-2024​)
9.2.1.3    Market Breakup by Type
9.2.1.4    Market Breakup by Clinical Practice
9.2.1.5    Market Breakup by End Use
9.2.1.6    Key Players
9.2.1.7    Market Forecast (2025-2033)
9.2.2    Japan
9.2.2.1    Market Drivers
9.2.2.2    Historical and Current Market Trends (​2019-2024​)
9.2.2.3    Market Breakup by Type
9.2.2.4    Market Breakup by Clinical Practice
9.2.2.5    Market Breakup by End Use
9.2.2.6    Key Players
9.2.2.7    Market Forecast (2025-2033)
9.2.3    India
9.2.3.1    Market Drivers
9.2.3.2    Historical and Current Market Trends (​2019-2024​)
9.2.3.3    Market Breakup by Type
9.2.3.4    Market Breakup by Clinical Practice
9.2.3.5    Market Breakup by End Use
9.2.3.6    Key Players
9.2.3.7    Market Forecast (2025-2033)
9.2.4    South Korea
9.2.4.1    Market Drivers
9.2.4.2    Historical and Current Market Trends (​2019-2024​)
9.2.4.3    Market Breakup by Type
9.2.4.4    Market Breakup by Clinical Practice
9.2.4.5    Market Breakup by End Use
9.2.4.6    Key Players
9.2.4.7    Market Forecast (2025-2033)
9.2.5    Australia
9.2.5.1    Market Drivers
9.2.5.2    Historical and Current Market Trends (​2019-2024​)
9.2.5.3    Market Breakup by Type
9.2.5.4    Market Breakup by Clinical Practice
9.2.5.5    Market Breakup by End Use
9.2.5.6    Key Players
9.2.5.7    Market Forecast (2025-2033)
9.2.6    Indonesia
9.2.6.1    Market Drivers
9.2.6.2    Historical and Current Market Trends (​2019-2024​)
9.2.6.3    Market Breakup by Type
9.2.6.4    Market Breakup by Clinical Practice
9.2.6.5    Market Breakup by End Use
9.2.6.6    Key Players
9.2.6.7    Market Forecast (2025-2033)
9.2.7    Others
9.2.7.1    Historical and Current Market Trends (​2019-2024​)
9.2.7.2    Market Forecast (2025-2033)
9.3    Europe
9.3.1    Germany
9.3.1.1    Market Drivers
9.3.1.2    Historical and Current Market Trends (​2019-2024​)
9.3.1.3    Market Breakup by Type
9.3.1.4    Market Breakup by Clinical Practice
9.3.1.5    Market Breakup by End Use
9.3.1.6    Key Players
9.3.1.7    Market Forecast (2025-2033)
9.3.2    France
9.3.2.1    Market Drivers
9.3.2.2    Historical and Current Market Trends (​2019-2024​)
9.3.2.3    Market Breakup by Type
9.3.2.4    Market Breakup by Clinical Practice
9.3.2.5    Market Breakup by End Use
9.3.2.6    Key Players
9.3.2.7    Market Forecast (2025-2033)
9.3.3    United Kingdom
9.3.3.1    Market Drivers
9.3.3.2    Historical and Current Market Trends (​2019-2024​)
9.3.3.3    Market Breakup by Type
9.3.3.4    Market Breakup by Clinical Practice
9.3.3.5    Market Breakup by End Use
9.3.3.6    Key Players
9.3.3.7    Market Forecast (2025-2033)
9.3.4    Italy
9.3.4.1    Market Drivers
9.3.4.2    Historical and Current Market Trends (​2019-2024​)
9.3.4.3    Market Breakup by Type
9.3.4.4    Market Breakup by Clinical Practice
9.3.4.5    Market Breakup by End Use
9.3.4.6    Key Players
9.3.4.7    Market Forecast (2025-2033)
9.3.5    Spain
9.3.5.1    Market Drivers
9.3.5.2    Historical and Current Market Trends (​2019-2024​)
9.3.5.3    Market Breakup by Type
9.3.5.4    Market Breakup by Clinical Practice
9.3.5.5    Market Breakup by End Use
9.3.5.6    Key Players
9.3.5.7    Market Forecast (2025-2033)
9.3.6    Others
9.3.6.1    Historical and Current Market Trends (​2019-2024​)
9.3.6.2    Market Forecast (2025-2033)
9.4    Latin America 
9.4.1    Brazil
9.4.1.1    Market Drivers
9.4.1.2    Historical and Current Market Trends (​2019-2024​)
9.4.1.3    Market Breakup by Type
9.4.1.4    Market Breakup by Clinical Practice
9.4.1.5    Market Breakup by End Use
9.4.1.6    Key Players
9.4.1.7    Market Forecast (2025-2033)
9.4.2    Mexico
9.4.2.1    Market Drivers
9.4.2.2    Historical and Current Market Trends (​2019-2024​)
9.4.2.3    Market Breakup by Type
9.4.2.4    Market Breakup by Clinical Practice
9.4.2.5    Market Breakup by End Use
9.4.2.6    Key Players
9.4.2.7    Market Forecast (2025-2033)
9.4.3    Others
9.4.3.1    Historical and Current Market Trends (​2019-2024​)
9.4.3.2    Market Forecast (2025-2033)
9.5    Middle East 
9.5.1    Market Drivers
9.5.2    Historical and Current Market Trends (​2019-2024​)
9.5.3    Market Breakup by Type
9.5.4    Market Breakup by Clinical Practice
9.5.5    Market Breakup by End Use
9.5.6    Market Breakup by Country
9.5.7    Key Players
9.5.8    Market Forecast (2025-2033)
9.6    Africa 
9.6.1    Market Drivers
9.6.2    Historical and Current Market Trends (​2019-2024​)
9.6.3    Market Breakup by Type
9.6.4    Market Breakup by Clinical Practice
9.6.5    Market Breakup by End Use
9.6.6    Market Breakup by Country
9.6.7    Key Players
9.6.8    Market Forecast (2025-2033)
9.7    Attractive Investment Proposition by Region
10    Market Dynamics
10.1    Market Driving Factors
10.2    Market Restraining Factors
10.3    Market Opportunities
11    Key Technological Trends & Development
12    Government Regulations and Strategies
13    Recent Industry News
14    Porters Five Forces Analysis

14.1    Overview
14.2    Bargaining Power of Buyers
14.3    Bargaining Power of Suppliers
14.4    Degree of Competition
14.5    Threat of New Entrants
14.6    Threat of Substitutes
15    Value Chain Analysis
16    Global Psychiatric Digital Biomarkers Market – Competitive Landscape 

16.1    Overview
16.2    Market Structure
16.3    Market Share by Key Players
16.4    Market Player Positioning
16.5    Top Winning Strategies
16.6    Competitive Dashboard
16.7    Company Evaluation Quadrant
17    Competitive Landscape
17.1    Empatica Inc
17.1.1    Business Overview
17.1.2    Services Offered
17.1.3    Business Strategies
17.1.4    SWOT Analysis
17.1.5    Major News and Events
17.2    iMediSync,Inc
17.2.1    Business Overview
17.2.2    Services Offered
17.2.3    Business Strategies
17.2.4    SWOT Analysis
17.2.5    Major News and Events
17.3    IXICO plc
17.3.1    Business Overview
17.3.2    Services Offered
17.3.3    Business Strategies
17.3.4    SWOT Analysis
17.3.5    Major News and Events
17.4    Kintsugi Mindful Wellness, Inc
17.4.1    Business Overview
17.4.2    Services Offered
17.4.3    Business Strategies
17.4.4    SWOT Analysis
17.4.5    Major News and Events
17.5    Koneksa Health
17.5.1    Business Overview
17.5.2    Services Offered
17.5.3    Business Strategies
17.5.4    SWOT Analysis
17.5.5    Major News and Events
17.6    Sonde Health, Inc.
17.6.1    Business Overview
17.6.2    Services Offered
17.6.3    Business Strategies
17.6.4    SWOT Analysis
17.6.5    Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

18    Strategic Recommendations
19    Appendix

Psychiatric Digital Biomarkers Market Size, Share, Trends and Forecast by Type, Clinical Practice, End Use, and Region, 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials